News Sentiment

LBRX sentiment intelligence

LB Pharmaceuticals Inc Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 59 Balanced news tone 61 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 32.95 Week of 10 Jul 2026
Weighted tone 59/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

75/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-1.4% over one week, +15.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

LB Pharmaceuticals Inc (NASDAQ:LBRX) Receives Average Recommendation of "Moderate Buy" from Brokerages

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 75/100 classification
One-week reaction -1.4% Price digesting
Trend fit Trend active 15.9% over four weeks
Fair value 42.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 28
Neutral 30
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
Stock Titan 6
TradingView 6
TradingKey 5
Investing.com 4
Moomoo 3
GlobeNewswire 3
simplywall.st 3

Event Lens

What the news is about

Classified themes
Market update 26
Earnings 22
Analyst action 10
Guidance 2
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 61